Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
Xavier Thuru, Romain Magnez, Hassiba El-Bouazzati, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3368-3368
Open Access | Times Cited: 11

Showing 11 citing articles:

Regulatory T cells in gastric cancer: Key controllers from pathogenesis to therapy
Ion Negură, Mariana Pavel, Mihai Danciu
Cancer Treatment Reviews (2023) Vol. 120, pp. 102629-102629
Closed Access | Times Cited: 18
Emerging Preclinical Applications of Humanized Mouse Models in the Discovery and Validation of Novel Immunotherapeutics and Their Mechanisms of Action for Improved Cancer Treatment
Isha Karnik, Zhisheng Her, Shu Hui Neo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1600-1600
Open Access | Times Cited: 15
Inside PD-1/PD-L1,2 with their inhibitors
Nicolas Boisgerault, Philìppe Bertrand
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115465-115465
Open Access | Times Cited: 14
Application of Nanotechnology and Phytochemicals in Anticancer Therapy
Jin Hee Kim, Boluwatife Olamide Dareowolabi, Rekha Thiruvengadam, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1169-1169
Open Access | Times Cited: 5
Helminth-induced immune modulation in colorectal cancer: exploring therapeutic applications
Hongyu Li, Chaojun Shan, Yunhuan Zhu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Characterization of research trends and prospects on hepatic echinococcosis over the past forty years: a bibliometric analysis
Tianen Li, Wei Su, Zhiqiang Wang, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 3
Niclosamide Prodrug Enhances Oral Bioavailability and Targets Vasorin-TGFβ Signaling in Hepatocellular Carcinoma
Mingdian Tan, Ye Wei, Yi Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway
Weifeng Xia, Xiaoli Zheng, Wenyi Liu, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 778-789
Closed Access
Research progress of intestinal microbiota in targeted therapy and immunotherapy of colorectal cancer
Xinying Zhou, Yu Zhao, Rongchuan Zhao, et al.
Journal of Cancer Metastasis and Treatment (2024)
Open Access
The Neuroimmune Axis and Its Therapeutic Potential for Primary Liver Cancer
Santosh K. Mandal, Poonam Yadav, Rahul A. Sheth
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6237-6237
Open Access
Using Helminths to Fight Cancer: An Innovative Approach
N. Ameli, Alireza Masoumi, Mahnaz Kerachi, et al.
World s Veterinary Journal (2023) Vol. 13, Iss. 4, pp. 606-616
Open Access | Times Cited: 1
Interaction of telmisartan and related sartans with the programmed cell death-ligand 1 (PD-L1) protein dimer: a molecular docking analysis
Gérard Vergoten, Christian Bailly
Future Journal of Pharmaceutical Sciences (2023) Vol. 9, Iss. 1
Open Access
Page 1

Scroll to top